Our animal experiments further indicate that butyrate activates the expression of the Ins1 and Ins2 genes in the pancreas and increases insulin-positive islets and serum C-peptide levels, thus improving glucose metabolism in butyrate-treated T1D mice, relative to that in untreated mice. Here, INS is linked to type 1 diabetes mellitus.